Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).

被引：3
|
作者：
Feldman, T. [1 ]
Mato, A. R. [1 ]
Zielonka, T. [1 ]
Masood, A. [1 ]
Goldberg, S. [1 ]
Rowley, S. D. [1 ]
Donato, M. [1 ]
Siegel, D. S. [1 ]
Pecora, A. [1 ]
Goy, A. [1 ]
机构：
[1] Hackensack Univ, Med Ctr, Hackensack, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.8067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic value of quantitative image analysis (QIA) for determination of proliferative index in mantle cell lymphoma (MCL) treated with sequential chemotherapy followed by high-dose therapy and autologous stem cell rescue (HDT/ASCR)
    Schaffel, R.
    Hedvat, C.
    Teruya-Feldstein, J.
    Portlock, C. S.
    Moskowitz, C. H.
    Zelenetz, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Preliminary results of a Nordic phase II study on dose-intensive induction and high-dose therapy (HDT) with autologous stem cell rescue (ASCR) as primary treatment for peripheral T-cell lymphomas (PTCL).
    d'Amore, F
    Holte, H
    Cavallin-Ståhl, E
    Enblad, G
    Jantunen, E
    Ralfkiaer, E
    Anderson, H
    Lauritzsen, G
    Hansen, M
    Telhaug, R
    Delabie, J
    Sundström, C
    BLOOD, 2003, 102 (11) : 292B - 292B
  • [3] High dose therapy (HDT) with autologous stem cell rescue for germ cell cancer.
    Gibson, J
    Eagle, C
    Boyer, M
    Grigg, A
    Prince, M
    Szer, J
    Bishop, J
    Joshua, D
    BLOOD, 1999, 94 (10) : 353A - 353A
  • [4] High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy
    Federico, M
    Bellei, M
    Brice, P
    Brugiatelli, M
    Nagler, A
    Gisselbrecht, C
    Moretti, L
    Colombat, P
    Luminari, S
    Fabbiano, F
    Di Renzo, N
    Goldstone, A
    Carella, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2320 - 2325
  • [5] High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma
    Vigouroux, Stephane
    Gaillard, Fanny
    Moreau, Philippe
    Harousseau, Jean-Luc
    Milpied, Noel
    HAEMATOLOGICA, 2005, 90 (11) : 1580 - 1582
  • [6] Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma
    Dreger, P
    vonNeuhoff, N
    Kuse, R
    Sonnen, R
    Glass, B
    Uharek, L
    Bartels, H
    Loffler, H
    Schmitz, N
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 401 - 403
  • [7] High dose therapy and autologous stem cell transplantation in mantle cell lymphoma
    Hiddemann, W
    Dreyling, M
    Parwaresch, R
    Unterhalt, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 49
  • [8] Advancement in high dose therapy and autologous stem cell rescue in lymphoma
    Isidori, Alessandro
    Clissa, Cristina
    Loscocco, Federica
    Guiducci, Barbara
    Barulli, Sara
    Malerba, Lara
    Gabucci, Elisa
    Visani, Giuseppe
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (07): : 1039 - 1046
  • [9] Front-Line High Dose Therapy with Following Autologous Stem Cell Transplantation (ASCT) for Follicular Lymphoma Patients
    Nesterova, Ekaterina S.
    Kravchenko, Sergey K.
    Kovrigina, Alla M.
    Gemdzhian, Eduard G.
    Magomedova, Aminat U.
    Bariakh, Elena A.
    Vorobyev, Vladimir I.
    Iliushkina, Ekaterina A.
    Mariin, Dmitry S.
    Chernova, Natalia G.
    Gavrilina, Olga A.
    Lukina, Anna E.
    Savchenko, Valeri G.
    BLOOD, 2014, 124 (21)
  • [10] Dose dense, high intensity induction therapy followed by early high dose chemotherapy (HDT) and autologous hematopoietic stem cell transplantation (AHSCT) for mantle cell lymphoma (MCL).
    Koh, LP
    Gockerman, JP
    Moore, JO
    DeCastro, C
    Long, GD
    Gasparetto, C
    Niedzwiecki, D
    Edwards, J
    Prosnitz, L
    Horwitz, M
    Chute, J
    Morris, A
    Lassiter, M
    Loftis, J
    Davis, P
    Chao, NJ
    Rizzieri, DA
    BLOOD, 2004, 104 (11) : 261A - 261A
12345